Atossa Genetics Inc (NASDAQ:ATOS)

1.54
Delayed Data
As of May 27
 +0.05 / +3.36%
Today’s Change
0.80
Today|||52-Week Range
2.65
+7.69%
Year-to-Date
No recent news for Atossa Genetics Inc.

Today’s Trading

Previous close1.49
Today’s open1.49
Day’s range-- - --
Volume237,809
Average volume (3 months)834,487
Market cap$40.6M
Dividend yield--
Data as of 05/27/2015

Growth & Valuation

Earnings growth (last year)+12.86%
Earnings growth (this year)+45.90%
Earnings growth (next 5 years)--
Revenue growth (last year)-16.85%
P/E ratioNM
Price/Sales65.36
Price/Book3.85

Competitors

 Today’s
change
Today’s
% change
EVOKEvoke Pharma Inc-0.01-0.20%
CYANCyanotech Corp+0.02+0.22%
XTLBX T L Biopharmaceuti...+0.05+2.66%
LFVNLifeVantage Corp+0.01+1.83%
Data as of 05/27/2015

Financials

Last reporting dateMay 13, 2015
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$526.0K
Annual profit (last year)-$14.7M
Net profit margin-2,786.92%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Steven C. Quay
Senior Vice President-
Operations
Scott Youmans
Corporate headquarters
Seattle, Washington

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers